Milk thistle pills protect the liver, lower enzymes, and repair liver damage
It is poorly absorbed and the liver quickly tags it for removal (phase II conjugation), so almost no free compound reaches liver cells. A Cochrane review found no effect on death or complications, and the SyNCH trial, at 3-5x the customary dose, was no better than placebo.
Why the claim spreads
It is the world's best-selling liver herb, and the pitch routinely invokes intravenous silibinin for death-cap poisoning. That use is genuine, but it is a different molecular form, a different route, and a different mechanism — the capsule cannot borrow its credit.
The mechanism, in brief
For those three things from the dish to happen in a person, the molecule first has to get inside the liver cell. The large trials that needed doing have been done, and they asked exactly whether that translates into better outcomes. The answer was negative.
Sources (4)
- Rambaldi, A., Jacobs, B. P., & Gluud, C. (2007). Milk thistle for alcoholic and/or hepatitis B or C virus liver diseases. Cochrane Database of Systematic Reviews, (4), CD003620. No significant effect on mortality or complications of liver disease.
- Fried, M. W., Navarro, V. J., Afdhal, N., Belle, S. H., Wahed, A. S., Hawke, R. L., et al. (2012). Effect of silymarin (milk thistle) on liver disease in patients with chronic hepatitis C unsuccessfully treated with interferon therapy: a randomized controlled trial. JAMA, 308(3), 274-282. SyNCH trial, N=154, silymarin 420 or 700 mg three times daily × 24 weeks vs placebo: no significant difference in decline of serum ALT and no difference in HCV RNA — higher-than-customary doses did not help.
- Wah Kheong, C., Nik Mustapha, N. R., & Mahadeva, S. (2017). A randomized trial of silymarin for the treatment of nonalcoholic steatohepatitis. Clinical Gastroenterology and Hepatology, 15(12), 1940-1949.e8. N=99, silymarin 700 mg three times daily × 48 weeks: the primary histological endpoint (≥30% reduction in NAFLD activity score without worsening fibrosis) was not met; a reduction in fibrosis score was a secondary finding.
- National Center for Complementary and Integrative Health. (2025). Milk Thistle: Usefulness and Safety. Trial results for liver disease have been 'conflicting or too limited to allow conclusions'; two NCCIH-funded trials (hepatitis C and nonalcoholic steatohepatitis) showed no benefit. Allergic reactions can occur in people allergic to ragweed, chrysanthemum, marigold, and daisy.